Why ketamine is different
Most antidepressants work on serotonin and take four to six weeks to show any effect. Ketamine works on a different system entirely — glutamate, the brain’s main excitatory neurotransmitter — and for many people, relief begins within hours to days rather than weeks. Yale researchers describe it as helping the brain regrow synaptic connections that chronic stress and depression have worn down.
Who it’s for
Ketamine is generally considered for treatment-resistant depression — typically defined as depression that hasn’t responded to at least two adequate trials of standard antidepressants. It is also studied for suicidal ideation, PTSD, and certain anxiety and OCD presentations. It is not a first-line treatment, and it is not right for everyone; a careful evaluation matters.
What a session looks like
In a clinical setting, ketamine is given at a low, sub-anesthetic dose — enough to soften the grip of rigid thought patterns without putting you under. Sessions are monitored, quiet, and typically an hour or two. When paired with therapy (ketamine-assisted therapy), the medicine creates a window in which trauma and stuck patterns become easier to process.
What it is not
Ketamine is not a cure and not a lifelong prescription. It is a tool — often a powerful one — that works best when combined with therapy, supportive relationships, and the ordinary work of building a life worth staying for. The goal is durable change, not dependence on the medicine.
Further reading
For a research-grounded overview from an academic medical center, see “How Ketamine Drug Helps with Depression” from Yale Medicine. Their piece includes a short explainer video with Yale psychiatrist Dr. Gerard Sanacora, who has led much of the foundational research on ketamine’s antidepressant effects.
Source credit: Yale Medicine. This article summarizes and links to their reporting; the video and full article remain on the Yale Medicine website.